Rituximab 500mg/50ml solution for infusion vials
NHS hospitals in England used £120,079,465 of indicative cost of Rituximab 500mg/50ml solution for infusion vials in the 12 months to July 2026, about 0.5% of all hospital medicines spend. That is up 2.3% on the previous 12 months.
Indicative cost · 12 months
Quantity (VMP units) · 12 months
Share of hospital medicines spend
Figure 1. Rituximab 500mg/50ml solution for infusion vials: NHS hospital indicative cost by month (£ millions)
Source: NHSBSA Secondary Care Medicines Data, to July 2026
Cost is indicative — actual hospital medicine prices are commercially confidential, so these figures are estimated from list prices. See methodology.
NHS trusts using Rituximab 500mg/50ml solution for infusion vials most
By indicative cost over the 12 months to July 2026.
| NHS trust | Indicative cost (12 months) |
|---|---|
| Barts Health Nhs Trust | £4,081,976 |
| Cambridge Univ Hosp Nhs Foundation Trust | £4,076,737 |
| The Newcastle Upon Tyne Hpl Nhs Found Tr | £3,965,848 |
| Univ Hpl B/Ham Nhs Foundation Trust | £3,959,648 |
| Imperial College Healthcare Nhs Trust | £3,867,181 |
| University College London Foundation Tr | £3,602,617 |
| University Hpls Of Leicester Nhs Trust | £3,224,543 |
| Guy's & St Thomas' Nhs Foundation Trust | £2,812,895 |
| Manchester University Nhs Ft | £2,761,948 |
| Leeds Teaching Hpls Nhs Trust | £2,566,974 |
The primary-care picture
Rituximab is also dispensed in the community. See the national primary-care prescribing volume, cost and trend on the Rituximab medicine page.